Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer

Summary

This multicenter, open-label, uncontrolled phase II trial evaluates safety and efficacy of post-operative chemoradiation in combination with cetuximab in squamous cell carcinoma of the head and neck.

Timeline

Start

2008-08

Primary completion

2013-04

Completion

2013-09

Publications

• Background Budach W, Bolke E, Homey B. Severe cutaneous reaction during radiation therapy with concurrent cetuximab. N Engl J Med. 2007 Aug 2;357(5):514-5. doi: 10.1056/NEJMc071075. No abstract available.

Drugs

Indications